MeterAnyway, now Ainz has turned upside down, and now the carnival is also in progress. The stupid constitution was read out on this day. A man in a tiger suit walks through the morning mist in Mainz, while a woman wears a large colorful mask. Michael Ebling About to fall under them. But the tall mayor of Mainz is still sitting in his office high above the city. Ebling is not usually overwhelmed by a joke. But today, in all this madness, he is very reserved and calm. Ebling said, of course he was very happy. But success also comes with responsibility.
Because suddenly his city is very rich. Mainz, which has been heavily indebted for a long time, sits on constantly emerging sources of funding. This is a bit like a lottery. Even now everyone in Mainz says that happiness is a matter of course. Ebling and the responsible treasurer announced this week that this year’s budget increase may exceed 1 billion euros. In the coming year, the surplus is expected to reach around 5 billion.Almost all the money goes to vaccine manufacturers Biological Technology return. The miracle of Mainz. The city now wants to stick to this, or most importantly, expand it. But can miracles be repeated?
In the gold mine, in all things
Biontech is headquartered in Upper Mainz. The address is in the gold mine, everything is inclusive. But for a long time, this company was not a gold mine at all. It swallowed millions, lined up one after another. So far, it has not achieved the actual goal of revolutionizing cancer research. So far, no drug has entered the market. But then there was a pandemic-Biontech quickly developed a groundbreaking vaccine. From January to September this year alone, the company achieved a pre-tax profit of 10.3 billion euros and sales of 13.4 billion euros. Thanks to Biontech, Mainz’s trade taxes have increased by more than five times.
If you are looking for an explanation of what is happening in the city, you will keep hearing: the right people are there. rich. Of course, the two are also related. In addition, policymakers in universities and politics have done nothing wrong.
On the screen on the first floor of the University Campus Institute of Molecular Biology (IMB), rows of numbers flashed on the screen. Amit Fulzele, IMB’s research assistant, stood in front of it. Fulzele grew up in India, studied and worked in France and the United States, but then decided to choose Mainz. He works in proteomics at IMB. There was a loud hum around him. For example, these are large mass spectrometers used to analyze the protein composition in cells and compare cancer cells with healthy cells. The cost of this equipment is approximately 1 million euros.
The institute is a non-profit limited liability company of the university. About 200 scientists from all over the world are here to study gene activity and genome stability. For example, they investigate why people get cancer or other diseases that are usually age-related. And the question of why people get old-after all, from a purely biological point of view, the body does not have to do this at all. Basic research may fundamentally change our lives.
